Description
The global slipped disc market is expected to exhibit potential growth during the forecast period. The key drivers responsible for the market growth are increasing number of spinal injuries, growing awareness of spinal non-fusion procedures and increasing prevalence of obesity.
The global slipped disc market is expected to reach USD 11,011.3 million by 2023 at a CAGR of 5.4% during the forecast period.
Global slipped disc market has been segmented on the basis of type which comprises of thoracic herniated discs, lumbar herniated disc and cervical herniated discs. Lumbar herniated disc captured the largest market share which was valued at USD 3,489.8 million in 2016.
On the basis of diagnosis, it is segmented into physical examination, nerve conduction test and imaging tests. Physical examination is the largest segment followed by imaging tests.
On the basis of treatment, this market is segmented into medications, therapy, and surgery. Medications captured the largest market share which was valued at USD 3,515.0 million in 2016.
On the basis regions, the market is segmented into regions namely Americas, Europe, Asia Pacific, and Middle East & Africa. The largest market share is captured by Americas, majorly due the increasing demand for specialty care services and rapid development of medical device industry.
Key Players:
The leading market players in the global slipped disc market include Captiva Spine, Inc. (U.S.), DePuy Synthes Companies (U.S.), GlaxoSmithKline plc (U.K), Globus Medical, Inc. (U.S.), NuVasive, Inc. (U.S.), Pfizer Inc. (U.S.), and TEVA Pharmaceutical LTD (Israel).
Study objectives of slipped disc market:
To provide insights about factors influencing and affecting the market growth
To provide historical and forecast revenues of the market segments and sub-segments with respect to regional and country-level markets
To provide historical and forecast revenue of the market segments based on types, products, applications, end users, and its sub-segments.
To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market.
Target Audience:
• Medical devices manufacturers
• Medical devices distributors
• Hospitals & Clinics
• Potential investors
• Key executive (CEO and COO) and strategy growth manager
Key Finding
• Imaging tests is the second largest market by type which is projected to grow at the CAGR of 5.7% during the forecast period from 2017-2023.
• Medications segment is expected to command the largest market share of around 5.1% in 2016.
• China holds the largest market share in the Asia Pacific slipped disc market and is expected to reach USD 587.0 million by 2023.
The reports also cover country level analysis:
• Americas
• North America
o U.S.
o Canada
• Latin America
• Europe
• Western Europe
o Germany
o France
o U.K
o Italy
o Spain
o Rest of Western Europe
• Eastern Europe
• Asia Pacific
• Japan
• China
• India
• Republic of Korea
• Rest of Asia-Pacific
• Middle East & Africa
• Middle East
• Africa
Table of Contents
1 Report Prologue
2 Introduction
2.1 Introduction
2.2 Research Objective
2.3 Assumptions & Limitations
2.3.1 Assumptions
2.3.2 Limitations
3 Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4 Market Dynamics
4.1 Drivers
4.1.1 Growing Cases of Spinal Injuries
4.1.2 Growing awareness of spinal non-fusion procedures
4.1.3 Growing Adoption of Sedentary Lifestyle
4.1.4 Growing Prevalence of Obese Population Affecting Spinal Injuries
4.2 Restrains
4.2.1 Treatment Cost
4.2.2 Ethical and Social Concerns
4.2.3 Complications Involved
4.3 Opportunities
4.3.1 Development of New Alternative Treatment Method
4.3.2 Botulinum-A Toxin Injections for Treatment Spinal Cord Injuries
4.3.3 Stem Cell Method in the Treatment in Spinal Injuries
5 Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Introduction
5.1.2 Bargaining Power of Suppliers
5.1.3 Bargaining Power of Buyers
5.1.4 Threat of New Entrants
5.1.5 Threat of Substitutes
5.1.6 Intensity of Rivalry
5.2 Value Chain Analysis
5.2.1 Introduction
5.2.2 Primary Activities
5.2.3 Secondary Activities
6 Global Slip disc market by Types
6.1 Introduction
6.2 Thoracic Herniated Discs
6.3 Lumbar Herniated Disc
6.4 Cervical Herniated Discs
7 Global Slip Disc Market, By Diagnosis
7.1 Introduction
7.2 Physical Examination
7.3 Nerve Conduction Test
7.4 Imaging Tests
8 Global Slip Disc Market, By Treatment
8.1 Introduction
8.2 Medications
8.3 Therapy
8.4 Surgery
9 Global Slip Disc Market, By Regions
9.1 Introduction
9.2 Americas
9.2.1 Americas
9.2.1.1 US
9.2.2 Canada
9.2.3 Latin America
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 UK
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Republic of Korea
9.4.5 Australia
9.4.6 Rest of Asia Pacific
9.5 Middle East & Africa
9.5.1 Middle East
9.5.2 Africa
10 Competitive landscape
10.1 Introduction
11 Company Profiles
11.1 Pfizer Inc.
11.1.1 Company Overview
11.1.2 Product/Business Segment Overview
11.1.3 Financial Updates
11.1.4 Key Developments
11.2 TEVA Pharmaceutical LTD.
11.2.1 Overview
11.2.2 Product/Business Segment Overview
11.2.3 Financials
11.2.4 Key Developments
11.3 GlaxoSmithKline plc.
11.3.1 Company Overview
11.3.2 Product overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 DePuy Synthes Companies (Part of Johnson & Johnson Services, Inc.)
11.4.1 Company Overview
11.4.2 Product Overview
11.4.3 Key Developments
11.4.4 Financials
11.4.5 SWOT Analysis
11.5 NuVasive, Inc.
11.5.1 Overview
11.5.2 Product Overview
11.5.3 Financials
11.5.4 Key Developments
11.6 Captiva Spine, Inc.
11.6.1 Overview
11.6.2 Product Overview
11.6.3 Financials
11.6.4 Key Development
11.7 Globus Medical, Inc.
11.7.1 Overview
11.7.2 Product Overview
11.7.3 Financials
11.7.4 Key Developments
